Icahn School of Medicine


Icahn School of Medicine at Mount Sinai Drives Collaborative Investigation into use of Nintedanib in COVID-19 Patients with Fibrosing ILD

New York City’s preeminent Icahn School of Medicine at Mount Sinai, Department of Medicine’s Clinical Trials Office (CTO) and collaborative partner Boehringer Ingelheim, the world’s largest privately held pharmaceutical company based in Germany, announced that the...

FAMILIA Study Harlem NY Shows Promise to Address Obesity & Cardiovascular Crisis with Disease Prevention Management

A recent study sponsored by Icahn School of Medicine, Mount Sinai and the American Heart Association found that both individual and group-based heart disease prevention management courses were more beneficial for reduced patient risk than standard lifestyle...

Pin It on Pinterest